What is the proper procedure and precautions for measuring plasma free metanephrines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Proper Procedure for Measuring Plasma Free Metanephrines

Blood must be drawn with the patient fully recumbent (supine) for at least 30 minutes before sampling, using reference intervals established in the same position. 1

Critical Sampling Protocol

Patient Positioning

  • Have the patient lie completely flat (supine) for a minimum of 30 minutes before blood draw 1
  • Seated sampling results in a 2.8-fold increase in false-positive results and a 3-fold increase in false-negative results 1
  • Plasma normetanephrine increases by 44% with outpatient versus inpatient sampling 2
  • Semi-recumbent positioning also increases false-positives compared to fully supine 2

Why this matters: Upright posture stimulates sympathetic activation and norepinephrine release, which is then metabolized to normetanephrine. This physiological response occurs in healthy individuals but NOT in patients with pheochromocytoma/paraganglioma (PPGL), making seated sampling particularly problematic—it increases false-positives in healthy people while potentially missing true cases 1.

Blood Collection Technique

  • Use an indwelling cannula rather than direct venipuncture 2
  • Direct venipuncture causes higher plasma concentrations and increased false-positive rates 2
  • Insert the cannula, then have the patient rest supine for 30 minutes before drawing blood

Environmental Considerations

  • Perform testing in warm conditions when possible 2
  • Cold temperatures increase false-positive rates for normetanephrine, particularly in outpatient settings 2
  • This effect is less pronounced with proper supine positioning but still relevant

Timing and Dietary Restrictions

  • If measuring 3-methoxytyramine (dopamine metabolite), draw blood after an overnight fast 1
  • For standard metanephrine and normetanephrine only, fasting is not required 1
  • Avoid physical exercise before sampling—it increases metanephrine by 82% and normetanephrine by 84% 3
  • Coffee increases normetanephrine by 20% 3

Medication Interference

Drugs That Cause False-Positives

Norepinephrine reuptake blockers (NRBs) are the primary medication concern:

  • Cause dose-dependent elevations in plasma normetanephrine and methoxytyramine 4
  • Consider short-term discontinuation if clinically safe, as levels normalize after withdrawal 4

Other interfering medications:

  • Tricyclic antidepressants (interfere with catecholamine disposition) 1
  • Acetaminophen, mesalamine, sulfasalazine (interfere with LC-ECD measurement methods) 1
  • Antipsychotics (increase methoxytyramine) 4
  • Nicotine use (increases methoxytyramine) 4

Important: Most commonly prescribed medications do NOT significantly interfere with plasma metanephrines 4. Chronic illness and cardiometabolic comorbidities also have minimal impact 4.

Sample Handling

  • Immediately centrifuge blood after collection 3
  • Store plasma at 4°C 3
  • Plasma is stable for 72 hours at 4°C 3
  • Avoid storage at room temperature (22°C), which reduces stability 3

Measurement Method Selection

Liquid chromatography with tandem mass spectrometry (LC-MS/MS) or electrochemical detection (LC-ECD) are superior to immunoassays 1, 5:

  • Higher diagnostic sensitivity (94% vs 91%) 5
  • Better precision and accuracy 1
  • Immunoassays underestimate plasma concentrations and have higher false-negative rates 1

If only immunoassay is available, consider referring patients or specimens to specialist centers with LC-MS/MS or LC-ECD capabilities 1.

Interpreting Results

When Results Are Borderline Positive

  • Repeat sampling with strict adherence to supine positioning 1
  • Most borderline elevations are due to inappropriate sampling 1
  • If still elevated, consider clonidine suppression test (97% sensitivity, 100% specificity for normetanephrine) 1
  • Alternative: measure urinary fractionated metanephrines 1

Marked Elevations (>3× Upper Limit of Normal)

  • Highly suggestive of PPGL 6
  • Marked elevations are uncommon (6%) in hypertensive emergencies without PPGL 6
  • Do not dismiss marked elevations as stress-related 6

Physiological Stress Considerations

  • Extreme illness (ICU settings) can cause false-positives 1
  • However, hypertensive emergency alone rarely causes marked elevations 6
  • Confirmatory testing after resolution of acute illness is appropriate 1

Common Pitfalls to Avoid

  1. Seated sampling is the most common error—it dramatically increases false-positives and false-negatives 1
  2. Using reference intervals from seated samples when blood was drawn supine (or vice versa)—reference intervals must match sampling position 1
  3. Testing during hypertensive emergency without clear PPGL suspicion—avoid routine screening in this setting 6
  4. Ignoring medication history—specifically check for NRBs 4
  5. Not allowing adequate supine rest time—full 30 minutes is required 1

Optimal Diagnostic Accuracy

Supine plasma free metanephrines measured by LC-MS/MS or LC-ECD provide 95% sensitivity and 95% specificity 5, making this the gold standard approach. This combination maintains constant 95% accuracy across all disease prevalence rates, superior to both seated sampling and 24-hour urine collections 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.